Menu
Not yet recruiting NCT06922773

Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity

Observational Early Life Adversity Microbiome, Human Anxiety Symptoms Depressive Symptoms

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Completion of questionnaires; child psychiatric screening; faecal sample analysis.
Who it may be relevant to
Registry conditions: Early Life Adversity, Microbiome, Human, Anxiety Symptoms, Depressive Symptoms. Basic parameters: 6 years — 13 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this observational study is to learn about the effects of early-life adversity (ELA) on the composition of children's microbiome and on their psychosocial functioning. The main questions it aims to answer are: * Do children who have experienced ELA have lower gut microbial diversity and/or an altered gut microbial composition? * Do these microbiome alterations correlate with adverse neurodevelopmental outcomes, including increased levels of stress, social and/or affective problems?

Interventions

  • Diagnostic test Completion of questionnaires; child psychiatric screening; faecal sample analysis
    Completion of questionnaires: * FFQ (Food Frequency Questionnaire) - completed by child * KIDSCREEN-10 - completed by child * CRIES-13 (Child Revised Impact of Events Scale) - completed by parents/guardian and child * CTES (Childhood Trust Events Survey) - completed by parents/guardian * RCADS-25 (Revised Children's Anxiety and Depression Scale) - completed by parents/guardian and child Child psychiatric screening using SCID-5-Junior - semi-structured interview conducted with child and parent(

Primary outcome measures

  • Global mental wellbeing [Time frame: Assessment at enrollment]
  • Microbiomial diversity [Time frame: Assessment based on single stool sample, within 4 weeks after enrollment]
Secondary outcome measures (5)
  • Post-traumatic stress symptoms [Time frame: Assessment at enrollment]
  • Anxiety and depression symptoms [Time frame: Assessment at enrollment]
  • Firmicutes/Bacteroidetes ratio [Time frame: Assessment based on single stool sample, within 4 weeks after enrollment]
  • Gut microbiomial composition [Time frame: Assessment based on single stool sample, within 4 weeks after enrollment]
  • Short-chain fatty acid metabolites [Time frame: Assessment based on single stool sample, within 4 weeks after enrollment]

Eligibility criteria

Inclusion criteria

  • Primary school-aged children (6 to 13 years of age) who have experienced at least one early-life traumatic event, based on the Childhood Trust Events Survey (CTES) questionnaire
  • The child and at least one of his/her parents (or guardian) speak Dutch sufficiently well to complete all of the questionnaires and the semi-structured child psychiatric interview (SCID-5-Junior)

Exclusion criteria

  • any chronic disorders or diseases known to affect the gut micobiome
  • inablity to complete questionnaires and/or semi-structured interview because of linguistic and/or cognitive barrier
  • congenital or acquired immunodeficiencies
  • use of medication(s) that affect gastrointestinal function (e.g., antibiotics) within the last 6 weeks, or laxatives within the last 4 weeks, or probiotic or prebiotic supplements within the last 4 weeks
  • current involvement in another clinical or food study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Belgium · 1 center
  • UZ Brussel — Jette

Identifiers

NCT: NCT06922773 · 23275_BELLYBRAIN

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗